Autologous Natural Killer Cell Therapy Produces Positive Results in 3 Sarcoma Case Studies
October 14th 2023Nadezhda Omelchenko, MD, a research associate at Cancer Center of Southern California in Santa Monica, discussed findings from patients treated with a combination therapy that included NK cell therapy SNK01.
Investing in Long-Term Studies May Provide a Better Picture of Cell Therapy Efficacy
August 30th 2023Adrian Kilcoyne, MD, MPH, MBA, the chief medical officer of Celularity, discussed what the company learned from relitigating results of legacy trials for a mesenchymal stem cell therapy in Crohn disease.